Femara (letrozole) to prevent recurrent breast cancer
November 2003
You'll see more women taking Femara (letrozole) to prevent recurrent breast cancer.
Tamoxifen is the standard of care for hormone-receptor-positive breast cancer. Taking it for 5 years reduces the risk of recurrence by 47% and improves survival.
But after 5 years tamoxifen's benefits wane.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive